It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. … READ MORE …
Filed under: Uncategorized | Tagged: African American, aggressiveness, decision-making, disparity, race, Treatment, white | 7 Comments »
The RESPOND study, which was initiated in July last year, appears to be the largest-ever study of risk factors for prostate cancer among the African American community, and probably among Black men worldwide. … READ MORE …
Filed under: Living with Prostate Cancer, Risk | Tagged: African American, epidemiology, research, RESPOND, risk | Leave a comment »
The National Cancer Institute has invested over $20 million in a new study that will attempt to enroll 10,000 African-American men who have been diagnosed with prostate cancer: the RESPOND study. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, environment, epidemiology, genetics, risk | Leave a comment »
It is relatively common knowledge — although never actually proven in a large, randomized, placebo-controlled trial — that statins like rosuvastatin (Crestor) and atorvastatin (Lipitor) may be helpful in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: African American, race, risk, statin, Treatment | 13 Comments »
In general, being of African American race is not a good thing when it comes to prostate cancer-related risk (for getting diagnosed with the disease or for outcomes over time). However, … … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: African American, Provenge, sipuleucel-T, Treatment | Leave a comment »
So there are two new articles recently published on the prostate cancer screening issue. One deals with the numbers of men in America who seem to be getting screened today. The other addresses whether there should be different guidance on prostate cancer screening for African Americans as opposed to “the rest of us” (Caucasians, Hispanics, and “white” Americans). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: African American, rates, research, screening | 4 Comments »
In an OpEd in today’s New York Times, there is a passionate plea for greater focus on the risks and dangers that prostate cancer presents to African-American men. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: African American, Diagnosis, Management, mortality, risk | 1 Comment »
There have been reports in the recent past that active surveillance may be less appropriate for African-American men than it is for others; and then there have been reports that did not show such an effect. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: active, African American, Caucasian, ethnicity, risk, surveillance | 1 Comment »
There have been a number of suggestions (as yet unproven) that African American men (and perhaps other men of black African ethnicity) may be less good candidates for active surveillance than men of Caucasian and Hispanic ethnicity. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, African American, density, ethnicity, Management, PSA, risk, surveillance | Leave a comment »
The appropriateness and utility of active surveillance as a management strategy for African-American men diagnosed with low-risk forms of prostate cancer appears to be becoming an issue of some mild controversy. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, African American, risk | 8 Comments »
There have been suggestions that genetic variations in subtypes of insulin-like growth factor 1 (IGF1) might be responsible for at least some of the increase in risk for prostate cancer among African Americans and others of historic African ethnicity such as Afro-Caribbeans. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: African American, IGF1, insulin growth factor | 2 Comments »
A recently published paper in the journal Urologic Oncology has confirmed that (regrettably but unsurprisingly), here in the USA, African-American men with high-risk prostate cancer are significantly less likely than white males to be given definitive treatment with curative intent. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: African American, insurance, risk, Treatment | Leave a comment »
In a number of papers dating back to the 1990s, Moul and colleagues clearly demonstrated that simply being African American places men with prostate cancer at greater risk for biochemical progression after surgical treatment than men of white race — even in an equal access health care system like that of the US military. … READ MORE …
Filed under: Management, Treatment | Tagged: African American, black, outcome, risk, surgery | 1 Comment »
Data to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) on Sunday, June 3, suggest that African American men with localized prostate cancer may be less likely that Caucasian men to respond well to active surveillance as a management strategy. However, this conclusion comes from a retrospective analysis of data from a relatively small, single-institution case series. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, African American, ethnicity, progression, race, risk | 1 Comment »
A new retrospective analysis of data from > 2,300 patients suggests that African-American men are a greater risk for biochemical disease recurrence after brachytherapy alone than Hispanics or Caucasian men, but … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: African American, brachytherapy, mortality, outcome, race, recurrence | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 